The co-evolved Helicobacter pylori and gastric cancer: Trinity of bacterial virulence, host susceptibility and lifestyle

Infectious Agents and Cancer

Volumn 2, Issue 1, 2007, Pages

  Akhter, Yusuf ^a   Ahmed, Irshad ^b   Devi, S Manjulata ^a   Ahmed, Niyaz ^a  

^a CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

^b SGB Amravati University   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34247874577     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-2-2     Document Type: Article

References (39)

1. Dunn BE, Cohen H, Blaser MJ: Helicobacter pylori. Clin Microbiol Rev 1997, 10:720-741.
2. Colding H, Hartzen SH, Roshanisefat H, Andersen LP, Krogfelt KA: Molecular methods for typing of Helicobacter pylori and their applications. FEMS Immunol 1999, 24:193-199.
3. Atherton JC: The pathogenesis of Helicobacter pylori -induced gastro-duodenal diseases. Annual Reviews in Pathology 2006, 1:63-96.
4. Devi SM, Ahmed I, Khan AA, Rahman SA, Alvi A, Sechi LA, Ahmed N: Genomes of Helicobacter pylori from native Peruvians suggest admixture of ancestral and modern lineages and reveal a western type cag-pathogenicity island. BMC Genomics 2006, 7:191.
5. Franchini M, Veneri D: Helicobacter pylori infection and immune thrombocytopenic purpura: an update. Helicobacter 2004, 9:342-346.
6. Jackson S, Beck PL, Pineo GF, Poon MC: Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature. Am J Hematol 2005, 78:142-150.
7. Pellicano R, Fagoonee S, Rizzetto M, Ponzetto A: Helicobacter pylori and coronary heart disease: Which directions for future studies? Crit Rev Microbiol 2003, 29:351-359.
8. Gasbarrini A, Carloni E, Gasbarrini G, Chisholm SA: Helicobacter pylori and extragastric diseases - other Helicobacters. Helicobacter 2004, 9:57-66.
9. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001, 345:784-789.
10. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ: Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995, 87:1777-1780.
11. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A: Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995, 55:2111-2115.
12. Parsonnet J, Friedman GD, Orentreich N, Vogelman H: Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997, 40:297-301.
13. Hatakeyama M: Oncogenic mechanisms of Helicobacter pylori cagA protein. Nature Rev Cancer 2004, 4:688-694.
14. Yamaoka Y, Kodama T, Kashima K, Graham DY, Sepulveda AR: Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pyolri-associated diseases. J Clin Microbiol 1998, 36:2258-2263.
15. Azuma T, Yamakawa A, Yamazaki S, Ohtani M, Ito Y, Muramatsu A, Suto H, Yamazaki Y, Keida Y, Higashi H, Hatakeyama M: Distinct diversity of the cog pathogenicity island among Helicobacter pylori strains in Japan. J Clin Microbiol 2004, 42:2508-2517.
16. Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC: Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. GastroenterologY 2004, 127:514-523.
17. Sunny L, Yeole BB, Hakama M, Shiri R, Mathews S, Falah Hassani K, Advani SH: Decreasing trend in the incidence of stomach cancer in Mumbai, India, during 1988 to 1999. Asian Pac J Cancer Prey 2004, 5:169-174.
18. Figueiredo C, Quint W, Nouhan N, van den Munckhof H, Herbrink P, Scherpenisse J, de Boer W, Schneeberger P, Perez-Perez G, Blaser MJ, van Doom LJ: Assessment of Helicobacter pylori vacA and cogA genotypes and host serological response. J Clin Microbiol 2001, 39:1339-1344.
19. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R: Helicobocter pylori Vacuolating Cytotoxin Inhibits T Lymphocyte Activation. Science 2003, 301:1099-1102.
20. Oliveira MJ, Costa AC, Costa AM, Henriques L, Suriano G, Atherton JC, Machado JC, Carneiro F, Seruca R, Mareel M, Leroy A, Figueiredo C: Helicobacter pylori Induces Gastric Epithelial Cell Invasion in a c-Met and Type IV Secretion System-dependent Manner. J Biol Chem 2006, 281:34888-34896.
21. Aviles-Jimenez F, Letley DP, Gonzalez-Valencia G, Salama N, Torres J, Atherton JC: Evolution of the Helicobacter pylori vacuolating cytotoxin in a human stomach, J Bacterial 2004, 186:5182- 5185.
22. Prouzet-Mauleon V, Hussain MA, Lamouliatte H, Kauser F, Megraud F, Ahmed N: Pathogen evolution in vivo : genome dynamics of two isolates obtained 9 years apart from a duodenal ulcer patient infected with a single Helicobacter pylori strain. J Clin Microbiol 2005, 43:4237-4241.
23. Aras RA, FischerW, Perez-Perez G I, Crosatti M.Ando T, Haas R, Blaser MJ: Plasticity of repetitive DNA sequences within a bacterial (Type IV) secretion system component. J Exp Med 2003, 198:1349-1360.
24. Kersulyte D, Chalkauskas H, Berg DE: Emergence of recombinant strains of Helicobacter pylori during human infection. Mol Microbiol 1999, 31:31-43.
25. Marshall BJ: The future of Helicobacter pylori eradication: a personal perspective. Aliment Pharmacol Ther 1997, 1:109-115.
26. Kuipers OP, Buist G, Kok J: Current strategies for improving food bacteria. Res Microbiol 2000, 151:815-822.
27. Carroll IM, Ahmed N, Beesley SM, Khan AA, Ghousunnissa S, Morain CA, Habibullah CM, Smyth CJ: Microevolution between paired antral and paired antrum and corpus Helicobacter pylori isolates recovered from individual patients. J Med Microbiol 2004, 53:669-677.
28. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, Williams C, Ardill JE, McColl KE: Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997, 113:15-24.
29. Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, Fraumeni JF Jr, Adami HO: The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996, 335:242-249.
30. Chakravorty M, Ghosh A, Choudhury A, Santra A, Hembrum J, Roychoudhury S: Interaction between ILIB gene promoter polymorphisms in determining susceptibility to Helicobacter pylori associated duodenal ulcer. Hum Mutat 2006, 27:411-419.
31. Abasiyanik MF, Tune M, Salih BA: Enzyme immunoassay and immunoblotting analysis of Helicobacter pylori infection in Turkish asymptomatic subjects. Diagn Microbiol Infect Dis 2004, 50:173-177.
32. Ahmed N: 23 years of the discovery of Helicobacter pylori : is the debate over? Ann Clin Microbiol Antimicrob 2005, 4:17.
33. Singh K, Ghoshal DC: Causal role of Helicobacter pylori infection in gastric cancer: an Asian enigma. World J Gastroenterol 2006, 12:1346-1351.
34. Miwa H, Go MF, Sato N: H pylori and gastric cancer: the Asian enigma. Am J Gastroenterol 2002, 97:1106-1112.
35. Khanna AK, Seth P, Nath G, Dixit VK, Kumar M: Correlation of Helicobacter pylori and gastric carcinoma. J Postgrad Med 2002, 48:27-28.
36. Ghoshal DC, Guha D, Bandyopadhyay S, Pal C, Chakraborty S, Ghoshal U, Ghosh TK, Pal BB, Banerjee PK: Gastric adenocarcinoma of MALT lymphoma with successful anti-H pylori therapy and in a patient re-infected with H pylori after regression gastric resection: a case report. BMC Gastroenterol 2002, 2:6.
37. Gajalakshmi CK, Shanta V: Lifestyle and risk of stomach cancer: a hospital-based case-control study. Int J Epidemiol 1996, 25:1 146-1153.
38. Mathew A, Gangadharan P, Varghese C, Nair MK: Diet and stomach cancer: a case-control study in South India. Eur J Cancer Prev 2000, 9:89-97.
39. National Cancer Registry Programme, India (Indian Council of Medical Research) [http://www.canceratlasindia.org/about.htm]